Thrombospondin 1 and Reelin act through Vldlr to regulate cardiac growth and repair

Lijuan Pei1, Zhaohui Ouyang1, Hongjie Zhang1

  • 1School of Life Sciences and Technology, Institute for Regenerative Medicine, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Shanghai East Hospital, Shanghai Institute of Stem Cell Research and Clinical Translation, Tongji University, 1239 Siping Road, Shanghai, 200092, China.

PubMed

Insights

Very-low-density-lipoprotein receptor (Vldlr) signaling suppresses cardiomyocyte proliferation, hindering heart repair. Targeting this pathway may improve cardiac regeneration after injury.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Signaling

Background:

  • Adult cardiomyocytes exhibit limited regenerative capacity post-injury, impacting heart repair.
  • Extracellular signals suppressing cardiomyocyte proliferation remain largely unknown.
  • Understanding these signals is crucial for developing cardiac regeneration therapies.

Purpose of the Study:

  • To identify extracellular signals regulating cardiomyocyte cell cycle.
  • To elucidate the role of very-low-density-lipoprotein receptor (Vldlr) in cardiomyocyte proliferation.
  • To investigate the impact of Vldlr signaling on cardiac regeneration.

Main Methods:

  • Profiling of receptors in postnatal cardiomyocytes.
  • Investigating the effects of Vldlr ligands (Reelin and Thrombospondin1) on cardiomyocyte proliferation.
  • Utilizing genetic mouse models with targeted gene deletions (Reln, Thbs1, Vldlr) and myocardial infarction.
  • Analyzing downstream signaling pathways including Rac1 and Yap.

Main Results:

  • Vldlr inhibits neonatal cardiomyocyte cell cycle proliferation.
  • Reelin promotes proliferation, while Thrombospondin1 (TSP-1) inhibits it via Vldlr.
  • TSP-1/Vldlr signaling regulates cardiomyocyte cell cycle through Rac1 and Yap.
  • Genetic disruption of Vldlr or TSP-1 enhances cardiomyocyte proliferation and cardiac repair.
  • Reln deficiency impairs neonatal cardiomyocyte proliferation and regeneration.

Conclusions:

  • Vldlr integrates extracellular signals to control cardiomyocyte cell cycle and survival.
  • The suppressive TSP-1-Vldlr axis contributes to the limited cardiac repair capacity in adult mammals.
  • Targeting Vldlr signaling presents a potential therapeutic strategy for enhancing cardiac regeneration.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K